Abstract: The invention relates to antigen-binding molecules that specifically bind to MHC Class I DLA-12 antigen. In one embodiment, the antigen-binding molecule is an antibody that specifically binds to canine MHC Class I DLA-12 antigen. Chimeric molecules of the antibody conjugated to another heterologous moiety are also provided. In one embodiment, the heterologous moiety is monomethyl auristatin E (MMAE). A method of inhibiting cancer using the antibody or the chimeric molecule thereof is also provided. In another embodiment, the antibody-MMAE conjugate suppresses tumour development in a murine model of B cell lymphoma.

Abstract: A processor-implemented method is disclosed. The method includes: obtaining account data for a first resource account; determining candidate values for at least one account attribute based on the account data for the first resource account; determining, for each candidate value, a numerical indicator representing a degree of truth of the at least one account attribute having the candidate value; selectively identifying services associated with the first resource account based on the numerical indicators; and generating notifications of the identified services for presenting to an accountholder of the first resource account.